Table 13.
Vaccines against Johne’s disease.
| Vaccine | Vector | Species | Dosage | Vaccination ages |
Immunity | Ref. |
|---|---|---|---|---|---|---|
| Mycopar® (Fort Dodge, KS, USA) |
Whole-cell bacterin containing inactivated Mycobacterium paratuberculosis bacteria suspended in oil |
Cattle, sheep |
Cattle: 0.5 ml sc. Sheep: 1 ml sc. |
Calves: less than 35 days Sheep: 3 months |
Cattle: ~90% effective in eliminating clinical disease Sheep: specific humoral and cellular responses elicited |
[106,107] |
| Silirum® (Pfizer, NY, USA) |
Killed bacteria in mineral oil adjuvant |
Cattle, deer |
One dose sc. for cattle and deer |
Calves: 14 days Deer: 5 months |
Cattle: no antibodies. Reduced colonization of tissues by pathogen Deer: reduced severity of disease |
[108,109] |
| DNA vaccine (Kathaperumal et al. 2008) |
Four rAgs (85A, 85B, 85C and superoxide dismutase) with two adjuvants (monophosphoryl lipid A and bovine IL-12) |
Cattle | 100 µg of each antigen and 100 µg of IL-12 im. |
5–10 days | Antibodies within 3 weeks; significant IFN-γ production within 11 weeks Significant increases in CD4+ and CD8+ T cells against all four rAgs; rAg-specific expression of IL-2, IL-12 and TNF-α. 4/8 animals did not show bacteria in tissue |
[104] |
| DNA vaccine (Sechi et al. 2005) |
Three rAgs (Mycobacterium avium 85A, BCG 85A and 65K) |
Sheep | Three doses of 1 mg of each antigen im. 20 days apart |
5 months | Increased IFN-γ and IL-10 expression, increased CD4+ T cells Absence of lesions and bacteria in tissues |
[105] |
Im.: Intramuscular; rAg: Recombinant antigen; sc.: Subcutaneous.